In addition, the use of brodalumab may be considered in patients where TNF-alpha is contraindicated or not responsive to TNF-alpha or not appropriate, such as those patients with multiple sclerosis [36,37] or congestive heart failure [38,39]. The gene discussed is TNF; the disease is congestive heart failure.